Balyasny Asset Management’s Medidata Solutions, Inc. MDSO Stock Holding History

Balyasny Asset Management’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-315,598	Closed	-$28.9M	–	1635
2019 Q3	$28.9M	Buy	315,598 +253,947	+412%	+$23.2M	0.2%	147
2019 Q2	$5.58M	Buy	+61,651	New	+$5.41M	0.04%	573
2018 Q1	–	Sell	-6,300	Closed	-$399K	–	2488
2017 Q4	$399K	Buy	+6,300	New	+$449K	﹤0.01%	1630
2015 Q1	–	Sell	-63,377	Closed	-$3.03M	–	1134
2014 Q4	$3.03M	Sell	63,377 -98,180	-61%	-$4.25M	0.03%	510
2014 Q3	$7.16M	Buy	+161,557	New	+$7.16M	0.06%	376

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Balyasny Asset Management's MDSO Position: Q4 2019 in Review

Balyasny Asset Management sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 315,598 shares — an estimated $28.9M sold.

Balyasny Asset Management first reported a position in MDSO in Q3 2014 and held it in 5 quarters. The position peaked at $28.9M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

Balyasny Asset Management reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
Balyasny Asset Management sold 315,598 Medidata Solutions, Inc. shares in Q4 2019, an estimated $28.9M.
Balyasny Asset Management first reported a position in Medidata Solutions, Inc. in Q3 2014 and held it in 5 quarters.
Balyasny Asset Management's Medidata Solutions, Inc. position peaked at $28.9M in Q3 2019.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Balyasny Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.